[go: up one dir, main page]

UY27741A1 - Supositorios de meloxicam - Google Patents

Supositorios de meloxicam

Info

Publication number
UY27741A1
UY27741A1 UY27741A UY27741A UY27741A1 UY 27741 A1 UY27741 A1 UY 27741A1 UY 27741 A UY27741 A UY 27741A UY 27741 A UY27741 A UY 27741A UY 27741 A1 UY27741 A1 UY 27741A1
Authority
UY
Uruguay
Prior art keywords
meloxicam
suppositories
pharmaceutically acceptable
active ingredient
consisting essentially
Prior art date
Application number
UY27741A
Other languages
English (en)
Inventor
Mayumi Matsui
Toshimitsu Ohki
Dr Koichi Wada
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of UY27741A1 publication Critical patent/UY27741A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a un supositorio que consiste esencialmente en el ingrediente activo meloxicam o una de sus sales farmacéuticamente aceptables y al menos un excipiente farmacéuticamente aceptable.
UY27741A 2002-03-30 2003-03-28 Supositorios de meloxicam UY27741A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02007455A EP1348436A1 (en) 2002-03-30 2002-03-30 Meloxicam suppositories

Publications (1)

Publication Number Publication Date
UY27741A1 true UY27741A1 (es) 2003-10-31

Family

ID=27798842

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27741A UY27741A1 (es) 2002-03-30 2003-03-28 Supositorios de meloxicam

Country Status (9)

Country Link
EP (2) EP1348436A1 (es)
JP (1) JP2005521714A (es)
AR (1) AR039184A1 (es)
AU (1) AU2003219113A1 (es)
CA (1) CA2479914A1 (es)
PE (1) PE20040308A1 (es)
TW (1) TW200306862A (es)
UY (1) UY27741A1 (es)
WO (1) WO2003082297A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
EP2488145B1 (en) 2009-10-12 2024-04-24 Boehringer Ingelheim Vetmedica GmbH Containers for compositions comprising meloxicam
SG183846A1 (en) 2010-03-03 2012-10-30 Boehringer Ingelheim Vetmed Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2756113A1 (de) * 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
JPH0816051B2 (ja) * 1988-12-07 1996-02-21 エスエス製薬株式会社 徐放性坐剤
JPH04346928A (ja) * 1991-05-24 1992-12-02 Doujin Iyaku Kako Kk 坐剤
JPH07100191A (ja) * 1993-10-06 1995-04-18 Daikyo Yakuhin Kogyo Kk 徐放性坐剤
EP0839029A1 (en) * 1995-07-20 1998-05-06 PHARMACIA & UPJOHN COMPANY Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules
WO1999009988A1 (en) * 1997-08-27 1999-03-04 Hexal Ag New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
EP0945134A1 (de) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen

Also Published As

Publication number Publication date
TW200306862A (en) 2003-12-01
PE20040308A1 (es) 2004-07-06
EP1492538A1 (en) 2005-01-05
EP1348436A1 (en) 2003-10-01
WO2003082297A1 (en) 2003-10-09
AU2003219113A1 (en) 2003-10-13
AR039184A1 (es) 2005-02-09
CA2479914A1 (en) 2003-10-09
JP2005521714A (ja) 2005-07-21

Similar Documents

Publication Publication Date Title
ECSP024399A (es) Derivados de benzotiazol
UY26380A1 (es) Inhibidores de fab i
HN2003000227A (es) Inhibidores de quinasas
CY1109523T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει ενα παραγωγο βενζοδιαζεπινης και εναν αναστολεα της πρωτεϊνης συντηξης rsv
ECSP088258A (es) Inhibidores de serina proteasas
UY27918A1 (es) Derivados de benzodioxol
CR7684A (es) Derivados de heterobiarilo como inhibidores de metaloproteinas de la matriz
UY28722A1 (es) Peptidos macrociclicos activos contra el virus del a hepatitis c
UY26512A1 (es) Inhibidores no peptídicos de la unión celúlar dependiente de vla - 4 útiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias
PA8556201A1 (es) Alquinos como inhibidores de metaloproteinasa de matriz
CR20120356A (es) Nuevos compuestos heterocíclicos activos como inhibidores de beta-lactamasas
CY1108036T1 (el) Κυτταρικη συσσωρευση φωσφονικων αναλογων ενωσεων αναστολεα πρωτεασης του ιου ανοσολογικης ανεπαρκειας του ανθρωπου (hiv) και οι ενωσεις ως τετοιες
LU92517I2 (fr) Delamanide et ses dérivés pharmaceutiquement acceptables
LU92326I2 (fr) Canakinumab et ses dérivés pharmaceutiquement acceptables (ILARIS)
ES2571779T3 (es) Inhibidores de cinasa a base de nicotinamida
ECSP045245A (es) N-aril-2-oxazolidinona-5-carboxamidas y sus derivados
CO6321285A2 (es) Uso de 3,11b-cis- dihidrotetrabenazina en el tratamiento de la esclerosis multiple y la mielitis autoinmunitaria
EP1556089A4 (en) INHIBITION OF GENE EXPRESSION USING RNA INTERFERENCE AGENTS
ECSP055745A (es) Derivados de 1-(4-bencil-piperazin-1-il)-3-fenil-propenona
AR049274A1 (es) Acido2-{[2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil]amino}-3-(fenilpiridin-2-ilamino)propionico sustancialmente puro como inhibidor selectivo de la quinasa ikk-2
UY26847A1 (es) Derivados de la pirrolidina
ECSP034561A (es) Derivados puente de piperazina
UY27741A1 (es) Supositorios de meloxicam
UY27074A1 (es) Derivados de aminotriazolopiridina
AR045724A1 (es) Composicion farmaceutica orodispersable de un compuesto antitrombotico

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150430